» Articles » PMID: 34633056

Knockdown of Long Noncoding RNA Colorectal Neoplasia Differentially Expressed Inhibits Hepatocellular Carcinoma Progression by Mediating the Expression of Nuclear Autoantigenic Sperm Protein

Overview
Journal Oncol Rep
Specialty Oncology
Date 2021 Oct 11
PMID 34633056
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) play critical roles in the tumorigenesis and progression of hepatocellular carcinoma (HCC). As the most common malignant cancer type in humans, HCC poses a great threat to human health. However, the function of lncRNA colorectal neoplasia differentially expressed (CRNDE) in HCC has not been extensively studied. The chief aim of the present study was to reveal the potential role of CRNDE in HCC. Expression levels of CRNDE in HCC tissues and cell lines were detected by reverse transcription‑quantitative (RT‑q) PCR, and Cell Counting kit 8, wound‑healing and Transwell assays were used to evaluate the influences of CRNDE on cellular proliferation, migration and invasiveness, respectively. The interaction between CRNDE and microRNA (miR)‑29c‑3p was determined by dual‑luciferase reporter assay, and rescue experiments were conducted to evaluate the interactive relationships between CRNDE and miR‑29c‑3p or nuclear autoantigenic sperm protein (NASP). CRNDE was found to be upregulated in HCC tissues and cells, and to be positively associated with the poor prognosis of patients with HCC. Furthermore, CRNDE‑knockdown suppressed cell proliferation, migration and invasion abilities. Bioinformatics and RT‑qPCR analysis indicated miR‑29c‑3p as a potential target of CRNDE. In line with previous reports, as a tumor suppressor, downregulated expression of miR‑29c‑3p was observed in HCC. In addition, the present study revealed that miR‑29c‑3p directly targeted NASP. NASP expression was markedly elevated following transfection with an miR‑29c‑3p inhibitor, while knocking down CRNDE inhibited NASP expression. Moreover, the effects of CRNDE and NASP on HCC cells were reversed by miR‑29c‑3p. Collectively, the results of the present study revealed that CRNDE was upregulated and exerted an oncogenic role in HCC by targeting miR‑29c‑3p, and that the upregulation of CRNDE also promoted NASP expression. These findings indicate a novel role for CRNDE in the progression of HCC.

Citing Articles

Decoding long non‑coding RNAs: Friends and foes in cancer development (Review).

Song H, Adu-Amankwaah J, Zhao Q, Yang D, Liu K, Bushi A Int J Oncol. 2024; 64(6).

PMID: 38695241 PMC: 11095623. DOI: 10.3892/ijo.2024.5649.

References
1.
Yu B, Chen X, Li J, Gu Q, Zhu Z, Li C . microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer. BMC Cancer. 2017; 17(1):109. PMC: 5294820. DOI: 10.1186/s12885-017-3096-9. View

2.
Zeng Z, Dong J, Li Y, Dong Z, Liu Z, Huang J . The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2019; 47(1):3067-3071. DOI: 10.1080/21691401.2019.1640228. View

3.
Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

4.
Kulik L, El-Serag H . Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2018; 156(2):477-491.e1. PMC: 6340716. DOI: 10.1053/j.gastro.2018.08.065. View

5.
Kang C, Qi B, Cai Q, Fu L, Yang Y, Tang C . LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating transcription. Theranostics. 2019; 9(15):4421-4436. PMC: 6599657. DOI: 10.7150/thno.32854. View